Literature DB >> 7066265

Macular vasculature, visual acuity, and irreversibly sickled cells in homozygous sickle cell disease.

R J Marsh, S M Ford, M F Rabb, R J Hayes, G R Serjeant.   

Abstract

Observations of visual acuity and the conjunctival, macular, and perimacular vascularity have been assessed in patients with homozygous sickle cell (SS) disease. There were 17 matched pairs, each consisting of one patient with a high count (greater than or equal to 15%) and one with a low count (less than or equal to 5%) of irreversibly sickled cells (ISCs). The macular vascular bed was assessed by measurements of the foveal avascular zone (FAZ), perimacular avascular zones, and counts of perimacular vascular abnormalities (perimacular counts). Small foveal avascular zones and high perimacular counts were commoner in younger than older patients and there was a significant inverse correlation between size of the FAZ and the perimacular count. These observations were compatible with the hypothesis that perimacular vessel anomalies represent the early vaso-occlusive phase which progresses to ischaemia and the formation and enlargement of avascular areas. Visual acuity was assessed by Snellen's test type and by measuring contrast sensitivity. There was no obvious relationship between acuity measured by the 2 methods and no relationship between acuity and observations of macular vascularity. High ISC counts were significantly related to abnormalities of the conjunctival vasculature, but no relationship was noted with abnormalities of the macular vasculature or with visual acuity.

Entities:  

Mesh:

Year:  1982        PMID: 7066265      PMCID: PMC1039743          DOI: 10.1136/bjo.66.3.155

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  6 in total

1.  Macular and perimacular vascular remodelling sickling haemoglobinopathies.

Authors:  G K Asdourian; K C Nagpal; B Busse; M Goldbaum; D Patriankos; M F Rabb; M F Goldberg
Journal:  Br J Ophthalmol       Date:  1976-06       Impact factor: 4.638

Review 2.  The importance of measuring contrast sensitivity in cases of visual disturbance.

Authors:  G B Arden
Journal:  Br J Ophthalmol       Date:  1978-04       Impact factor: 4.638

3.  Sickling hemoglobinopathies; macular and perimacular vascular abnormalities.

Authors:  T S Stevens; B Busse; C B Lee; M B Woolf; S O Galinos; M F Goldberg
Journal:  Arch Ophthalmol       Date:  1974-12

4.  The conjunctival sign in sickle cell anemia. A relationship with irreversibly sickled cells.

Authors:  G R Serjeant; B E Serjeant; P I Condon
Journal:  JAMA       Date:  1972-03-13       Impact factor: 56.272

5.  The Arden grating test of visual function: a preliminary study of its practicability and application in a rural community in north-west Iran.

Authors:  D C Minassian; B R Jones; A Zargarizadeh
Journal:  Br J Ophthalmol       Date:  1978-04       Impact factor: 4.638

6.  A simple grating test for contrast sensitivity: preliminary results indicate value in screening for glaucoma.

Authors:  G B Arden; J J Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  1978-01       Impact factor: 4.799

  6 in total
  5 in total

1.  Alpha thalassaemia and the macular vasculature in homozygous sickle cell disease.

Authors:  P I Condon; R J Marsh; G H Maude; D R Higgs; D J Weatherall; G R Serjeant
Journal:  Br J Ophthalmol       Date:  1983-11       Impact factor: 4.638

2.  The objective assessment of contrast sensitivity function by electrophysiological means.

Authors:  J W Howe; K W Mitchell
Journal:  Br J Ophthalmol       Date:  1984-09       Impact factor: 4.638

3.  Recurrent visual loss in homozygous sickle cell disease.

Authors:  P I Condon; R A Whitelocke; A C Bird; J F Talbot; G R Serjeant
Journal:  Br J Ophthalmol       Date:  1985-09       Impact factor: 4.638

4.  Acuity and contrast sensitivity.

Authors:  R Sekuler; P Mulvanny
Journal:  Br J Ophthalmol       Date:  1983-02       Impact factor: 4.638

5.  Foveal avascular zone in macular branch retinal vein occlusion.

Authors:  M B Parodi; F Visintin; P Della Rupe; G Ravalico
Journal:  Int Ophthalmol       Date:  1995       Impact factor: 2.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.